Quick Answer
TEVA PHARMACEUTICAL INDUSTRIES LTD reported Net Income of $1.41 billion for fiscal year 2025.
TEVA PHARMACEUTICAL INDUSTRIES LTD Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $1.41B | +186.0% |
| 2024 | -$1.64B | -193.2% |
| 2023 | -$559.00M | +77.1% |
| 2022 | -$2.45B | -686.6% |
| 2021 | $417.00M | +110.5% |
| 2020 | -$3.99B | -299.4% |
| 2019 | -$999.00M | +53.5% |
| 2018 | -$2.15B | +86.8% |
| 2017 | -$16.27B | -5043.8% |
| 2016 | $329.00M | -79.3% |
| 2015 | $1.59B | -48.0% |
| 2014 | $3.06B | +140.7% |
| 2013 | $1.27B | -35.4% |
| 2012 | $1.96B | -28.9% |
| 2011 | $2.76B | -17.2% |
| 2010 | $3.33B | +66.5% |
| 2009 | $2.00B | +228.4% |
| 2008 | $609.00M | -68.2% |
| 2007 | $1.91B | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $433.00M | +199.1% | +53.5% |
| June 30, 2025 | $282.00M | +133.3% | +31.8% |
| March 31, 2025 | $214.00M | +254.0% | +149.0% |
| September 30, 2024 | -$437.00M | -733.3% | +48.3% |
| June 30, 2024 | -$846.00M | +3.0% | -508.6% |
| March 31, 2024 | -$139.00M | +36.8% | -301.4% |
| September 30, 2023 | $69.00M | +23.2% | +107.9% |
| June 30, 2023 | -$872.00M | -275.9% | -296.4% |
- TEVA PHARMACEUTICAL INDUSTRIES LTD showed an increase of +186.0% in Net Income compared to the prior fiscal year.
- Over the 2007–2025 period, TEVA PHARMACEUTICAL INDUSTRIES LTD’s net income has declined by 26.3% (from $1.91 billion to $1.41 billion).
- The most recent figure is from TEVA PHARMACEUTICAL INDUSTRIES LTD’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: